Foresite Capital Management V, Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$271.0M
Q ending 2026-03-31
Prior quarter
$164.4M
Q ending 2025-12-31
Change
+64.8% QoQ · +209.3% YoY
Positions
9
reported holdings
Largest positions
All 9 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Alumis Inc. | ALMS | Shares | $129.9M | 5.9M |
| Cg Oncology, Inc. | CGON | Shares | $68.0M | 1.0M |
| Disc Medicine, Inc. | IRON | Shares | $23.9M | 374K |
| Hims & Hers Health, Inc. | HIMS | Shares | $15.3M | 738K |
| Eikon Therapeutics, Inc. | EIKN | Shares | $14.0M | 1.3M |
| Lyell Immunopharma, Inc. | LYEL | Shares | $9.6M | 477K |
| Pharvaris N.V. | Shares | $5.5M | 194K | |
| Nurix Therapeutics, Inc. | NRIX | Shares | $4.1M | 265K |
| Maze Therapeutics, Inc. | MAZE | Shares | $773K | 26K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.